News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 8 August 2026.

Net profit of Par Drugs & Chemicals declined 48.48% to Rs 0.85 crore in the quarter ended March 2026 as against Rs 1.65 crore during the previous quarter ended March 2025. Sales declined 12.18% to Rs 19.61 crore in the quarter ended March 2026 as against Rs 22.33 crore during the previous quarter ended March 2025.For the full year,net profit declined 1.87% to Rs 13.11 crore in the year ended March 2026 as against Rs 13.36 crore during the previous year ended March 2025. Sales rose 2.66% to Rs 103.66 crore in the year ended March 2026 as against Rs 100.97 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales19.6122.33 -12 103.66100.97 3 OPM %7.2910.88 -16.5319.32 - PBDT1.753.20 -45 21.0021.58 -3 PBT0.822.28 -64 17.3017.93 -4 NP0.851.65 -48 13.1113.36 -2 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Net profit of Par Drugs & Chemicals rose 727.59% to Rs 4.80 crore in the quarter ended December 2025 as against Rs 0.58 crore during the previous quarter ended December 2024. Sales rose 37.23% to Rs 29.34 crore in the quarter ended December 2025 as against Rs 21.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales29.3421.38 37 OPM %20.626.64 - PBDT7.371.68 339 PBT6.440.77 736 NP4.800.58 728 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live News